RNU6-1223P

Across TCGA pan-cancer cohorts, RNU6-1223P RNA is linked to patient survival in 22 of 34 cancer types, making it the most broadly survival-associated RNU6-1223P data layer.

The strongest signal is observed in adrenocortical carcinoma (ACC), where higher RNU6-1223P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RNU6-1223P expression acts as an unfavorable survival marker, although some lineages such as HNSC and BLCA show a favorable association.

ACC, MESO, and LIHC are the cancer types where RNU6-1223P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ACC	DFS	Median	II,III,IV	0.365	0.708	<.001	93	view →
MESO	OS	Median	IV	0.308	0.847	<.001	65	view →
LIHC	DFS	Tertile	All	0.333	0.487	<.001	45	view →
HNSC	OS	Median	III,IV	0.439	0.210	<.001	43	view →
THCA	OS	Tertile	III,IV	0.595	1.000	<.001	32	view →
BLCA	DFS	Quartile	III,IV	0.553	0.414	.018	30	view →
UCEC	DFS	Median	II,III,IV	0.622	0.799	.001	30	view →
READ	OS	Median	II,III,IV	0.798	0.399	.001	30	view →
KICH	DFS	Tertile	All	0.555	1.000	.004	25	view →
UCS	DFS	Tertile	IV	0.938	0.361	.024	18	view →
KIRC	DFS	Tertile	All	0.458	0.657	.013	18	view →
ESCA	OS	Median	All	0.776	0.566	<.001	16	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 22 lineages.

RNU6-1223P–ACC (DFS)

Open the ACC breakdown →